Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease

Autor: Neumann, H, Neurath, Mf, Vieth, M, Lever, Fm, Meijer, Gj, Lips, Im, Mcmahon, Bp, Ruurda, Jp, van Hillegersberg, R, Siersema, P, Levine, Ms, Scharitzer, M, Pokieser, P, Zerbib, F, Savarino, V, Zentilin, P, Savarino, EDOARDO VINCENZO, Chan, Ww

Publikováno v: Annals of the New York Academy of Sciences. 1300

This paper reporting on techniques for esophageal evaluation and imaging and drugs for esophageal disease includes commentaries on endoscopy techniques including dye-based high-resolution and dye-less high-definition endoscopy; the shift from CT to M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::75a003fe4e55257fed924c049c287305
https://pubmed.ncbi.nlm.nih.gov/24117631

High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients.

Autor: Lips IM, Dehnad H, van Gils CH, Boeken Kruger AE, van der Heide UA, van Vulpen M, Lips, Irene M, Dehnad, Homan, van Gils, Carla H, Boeken Kruger, Arto E, van der Heide, Uulke A, van Vulpen, Marco

Publikováno v: Radiation Oncology; 2008, Vol. 3, p15-15, 1p

Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient's IADL?

Autor: Oort Q; Department of Neurology and Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands., Sikkes SAM; Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Aaronson N; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Boele F; Leeds Institute of Medical Research, St James's University Hospital, Leeds, UK., Brannan C; East & North Hertfordshire NHS Trust incorporating Mount Vernon Cancer Centre, Northwood, UK., Egeter J; Department for Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria., Grant R; Department of Clinical Neurosciences, Western General Hospital, Edinburgh, UK., Klein M; Department of Medical Psychology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Lips IM; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands., Narita Y; Department of Neurosurgery and Neuro-Oncology, National Cancer Center, Tokyo, Japan., Sato H; Department of Neurosurgery and Neuro-Oncology, National Cancer Center, Tokyo, Japan., Sztankay M; Department for Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria., Stockhammer G; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Talacchi A; Department of Neurosurgery, Azienda Ospedaliera San Giovanni Addolorata, Roma, Italy., Uitdehaag BMJ; Department of Neurology and Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Reijneveld JC; Department of Neurology and Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Taphoorn MJB; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: Neuro-oncology practice [Neurooncol Pract] 2022 Feb 26; Vol. 9 (4), pp. 271-283. Date of Electronic Publication: 2022 Feb 26 (Print Publication: 2022).

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer.

Autor: van Pelt GW; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., Krol JA; Department of Radiotherapy, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., Lips IM; Department of Radiotherapy, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., Peters FP; Department of Radiotherapy, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., van Klaveren D; Department of Medical Statistics, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., Boonstra JJ; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., de Steur WO; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., Tollenaar RAEM; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., Farina Sarasqueta A; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., Mesker WE; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., Slingerland M; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands.

Publikováno v: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2019 Nov 27; Vol. 20, pp. 39-44. Date of Electronic Publication: 2019 Nov 27 (Print Publication: 2020).

Gross Tumor Delineation in Esophageal Cancer on MRI Compared With ¹⁸ F-FDG-PET/CT.

Autor: Vollenbrock SE; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Nowee ME; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Voncken FEM; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kotte ANTJ; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Goense L; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands., van Rossum PSN; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., van Lier ALHMW; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Heijmink SW; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Bartels-Rutten A; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Wessels FJ; Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands., Aleman BMP; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Dewit L; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kerkmeijer LGW; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Jansen EPM; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Intven M; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Lips IM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands., Meijer GJ; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Nijkamp J; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Publikováno v: Advances in radiation oncology [Adv Radiat Oncol] 2019 Apr 24; Vol. 4 (4), pp. 596-604. Date of Electronic Publication: 2019 Apr 24 (Print Publication: 2019).